Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Pediatric Rheumatology
Published in: Pediatric Rheumatology 1/2013

Open Access 01-12-2013 | Research

Pain experience in children with juvenile idiopathic arthritis treated with anti-TNF agents compared to non-biologic standard treatment

Authors: Johanne Jeppesen Lomholt, Mikael Thastum, Troels Herlin

Published in: Pediatric Rheumatology | Issue 1/2013

Login to get access

Abstract

Background

Anti-TNF agents have proven efficacy in children with severe juvenile idiopathic arthritis (JIA) who are unresponsive to standard therapy. Therefore pain reduction or elimination could be expected. The aim of this study was to compare the pain experience in children with JIA treated with anti-TNF agents (n = 41) or non-biologic standard treatment (n = 50).

Methods

All children completed a 2-week pain diary and, for children treated with anti-TNF agents, measures of pain-coping and pain-specific beliefs. Parents rated the child’s level of functional disability. Clinical data were collected from the pediatric rheumatologists.

Results

No significant differences were found between the anti-TNF group and non-biologic standard treatment group for average pain score, number of children with daily pain reported in the pain diary, or level of functional disability. Significantly more children in the anti-TNF group reported no pain at all. Children undergoing standard treatment had significantly higher disease activity. Significant differences were found between the high pain patients treated with anti-TNF agents and the rest of the anti-TNF group in regards to their pain-specific beliefs of disability and harm, and the pain-coping strategy of catastrophizing.

Conclusion

These results indicate that a great proportion of children treated with anti-TNF agents respond well to the treatment in regards to disease activity and pain, but pain was still a problem for a subgroup of children though they were in remission with biological agents. More focus on pain management is needed.
Literature
1.
Schanberg LE, Anthony KK, Gil KM, Maurin EC: Daily pain and symptoms in children with polyarticular arthritis. Arthritis Rheum. 2003, 48: 1390-1397. 10.1002/art.10986.CrossRefPubMed
2.
Benestad B, Vinje O, Veierød MB, Vandvik IH: Quantitative and qualitative assesment of pain in children with juvenile chronic arthritis based on the norwegian version of the Pediatric Pain Questionnaire. Scan J Rheumatol. 1996, 25: 293-299. 10.3109/03009749609104061.CrossRef
3.
Sherry DD, Bohnsack J, Salmonson K, Wallace CA, Mellins E: Painless Juvenile Rheumatoid-Arthritis. J Pediatr. 1990, 116: 921-923. 10.1016/S0022-3476(05)80652-3.CrossRefPubMed
4.
Giannini EH, Brewer EJ, Kuzmina N, Shaikov A, Maximov A, Vorontsov I, Fink CW, Newman AJ, Cassidy JT, Zemel LS: Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children’s Study Group. N Engl J Med. 1992, 326: 1043-1049. 10.1056/NEJM199204163261602.CrossRefPubMed
5.
Ruperto N, Murray KJ, Gerloni V, Wulffraat N, de Oliveira SK, Falcini F, Dolezalova P, Alessio M, Burgos-Vargas R, Corona F, Vesely R, Foster H, Davidson J, Zulian F, Asplin L, Baildam E, Consuegra JG, Ozdogan H, Saurenmann R, Joos R, Pistorio A, Woo P, Martini A: A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis Rheum. 2004, 50: 2191-2201. 10.1002/art.20288.CrossRefPubMed
6.
Woo P, Southwood TR, Prieur AM, Dore CJ, Grainger J, David J, Ryder C, Hasson N, Hall A, Lemelle I: Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Arthritis Rheum. 2000, 43: 1849-1857. 10.1002/1529-0131(200008)43:8<1849::AID-ANR22>3.0.CO;2-F.CrossRefPubMed
7.
Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Whitmore J, Finck BK: The Pediatric Rheumatology Collaborative Study Group. Etanercept in Children with Polyarticular Juvenile Rheumatoid Arthritis. N Engl J Med. 2000, 342: 763-769. 10.1056/NEJM200003163421103.CrossRefPubMed
8.
Lovell DJ, Ruperto N, Goodman S, Reiff A, Jung L, Jarosova K, Nemcova D, Mouy R, Sandborg C, Bohnsack J, Elewaut D, Foeldvari I, Gerloni V, Rovensky J, Minden K, Vehe RK, Weiner LW, Horneff G, Huppertz HI, Olson NY, Medich JR, Carcereri-De-Prati R, McIlraith MJ, Giannini EH, Martini A, the Pediatric Rheumatology Collaborative Study Group and the Pediatric Rheumatology International Trials Organisation: Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis. N Engl J Med. 2008, 359: 810-820. 10.1056/NEJMoa0706290.CrossRefPubMed
9.
Ruperto N, Lovell DJ, Cuttica R, Wilkinson N, Woo P, Espada G, Wouters C, Silverman ED, Balogh Z, Henrickson M, Apaz MT, Baildam E, Fasth A, Gerloni V, Lahdenne P, Prieur AM, Ravelli A, Saurenmann PK, Gamir ML, Wulffraat N, Marodi L, Petty RE, Joos R, Zulian F, McCurdy D, Myones BL, Nagy K, Reuman P, Szer I, Travers S: A Randomized, Placebo-Controlled Trial of Infliximab Plus Methotrexate for the Treatment of Polyarticular-Course Juvenile Rheumatoid Arthritis. Arthritis Rheum. 2007, 56: 3096-3106. 10.1002/art.22838.CrossRefPubMed
10.
Gartlehner G, Hansen RA, Jones BA, Thieda P, Lohr KN: Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence. Clin Rheumatol. 2008, 27: 67-76. 10.1007/s10067-008-0936-7.CrossRefPubMed
11.
Lovell DJ, Reiff A, Jones OY, Schneider R, Nocton J, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Whitmore JB, White B, Giannini EH: Long-Term Safety and Efficacy of Etanercept in Children With Polyarticular-Course Juvenile Rheumatoid Arthritis. Arthritis Rheum. 2006, 54: 1987-1994. 10.1002/art.21885.CrossRefPubMed
12.
Lovell DJ, Reiff A, Ilowite NT, Wallace CA, Chon Y, Lin SL, Baumgartner SW, Giannini EH: Safety and Efficacy of up to Eight Years of Continuous Etanercept Therapy in Patients With Juvenile Rheumatoid Arthritis. Arthritis Rheum. 2008, 58: 1496-1504. 10.1002/art.23427.CrossRefPubMed
13.
Lovell DJ, Giannini EH, Reiff A, Jones OY, Schneider R, Olson JC, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Lange M, Finck BK, Burge DJ: Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: Interim results from an ongoing multicenter, open-label, extended-treatment trial. Arthritis Rheum. 2003, 48: 218-226. 10.1002/art.10710.CrossRefPubMed
14.
Prince FHM, Geerdink LM, Borsboom GJJM, Twilt M, van Rossum MAJ, Hoppenreijs EPAH: Cate Rt, Koopman-Keemink Y, van Santen-Hoeufft M, Raat H, van Suijlekom-Smit LA. Major improvements in health-related quality of life during the use of etanercept in patients with previously refractory juvenile idiopathic arthritis. Ann Rheum Dis. 2010, 69: 138-142. 10.1136/ard.2009.111260.CrossRefPubMed
15.
Kimura Y, Walco GA: Treatment of chronic pain in pediatric rheumatic disease. Nat Clin Pract Rheumatol. 2007, 3: 210-218.CrossRefPubMed
16.
Thompson KL, Varni JW, Hanson V: Comprehensive assesment of pain in juvenile rheumatoid arthritis: an empirical model. J Pediatr Psychol. 1987, 12: 241-255. 10.1093/jpepsy/12.2.241.CrossRefPubMed
17.
Schanberg LE, Keefe FJ, Lefebvre JC, Kredich D, Gil KM: Pain coping and the pain experience in children with juvenile chronic arthritis. Pain. 1997, 73: 181-189. 10.1016/S0304-3959(97)00110-3.CrossRefPubMed
18.
Ilowite NT, Walco GA, Pochaczevsky R: Assesment of pain in patients with juvenile rheumatoid arthritis: Relation between pain intensity and degree of joint inflammation. Ann Rheum Dis. 1992, 51: 343-346. 10.1136/ard.51.3.343.PubMedCentralCrossRefPubMed
19.
Hagglund KJ, Schopp LM, Alberts KR, Cassidy JT, Frank RG: Predicting pain among children with juvenile rheumatoid arthritis. Arthritis Care Res. 1995, 8: 36-42. 10.1002/art.1790080109.CrossRefPubMed
20.
Malleson PN, Oen K, Cabral DA, Petty RE, Rosenberg AM, Cheang M: Predictors of pain in children with established juvenile rheumatoid arthritis. Arthritis Care Res. 2004, 51: 222-227. 10.1002/art.20238.CrossRef
21.
Thastum M, Herlin T, Zachariae R: Relationship of pain-coping strategies and pain-specific beliefs to pain experience in children with juvenile idiopathic arthritis. Arthritis Rheum. 2005, 53: 178-184. 10.1002/art.21081.CrossRefPubMed
22.
Thastum M, Zachariae R, Herlin T: Pain experience and pain coping strategies in children with juvenile idiopathic arthritis. J Rheumatol. 2001, 28: 1091-1098.PubMed
23.
Thastum M, Herlin T: Pain-specific beliefs and pain experience in children with juvenile idiopathic arthritis: a longitudinal study. J Rheumatol. 2011, 38: 155-160. 10.3899/jrheum.091375.CrossRefPubMed
24.
Lazarus R, Folkman S: Stress, Appraisal, and Coping. 1984, New York: Springer Publishing Company
25.
Varni JW, Waldron SA, Gragg RA, Rapoff MA, Bernstein BH, Lindsley CB, Newcomb MD: Development of the Waldron/Varni Pediatric Pain Coping Inventory. Pain. 1996, 67: 141-150. 10.1016/0304-3959(96)03077-1.CrossRefPubMed
26.
Reid GJ, Gilbert CA, McGrath PJ: The Pain Coping Questionnaire: preliminary validation. Pain. 1998, 76: 83-96. 10.1016/S0304-3959(98)00029-3.CrossRefPubMed
27.
Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He H, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, Suarez-Almazor M, Woo P: International League of Associations for Rheumatology Classification of Juvenile Idiopathic Arthritis: Second Revision, Edmonton, 2001. J Rheumatol. 2004, 31: 390-392.PubMed
28.
Hicks CL, von Baeyer CL, Spafford PA, van Korlaar I, Goodenough B: The Faces Pain Scale - Revised: toward a common metric in pediatric pain measurement. Pain. 2001, 93: 173-183. 10.1016/S0304-3959(01)00314-1.CrossRefPubMed
29.
Tomlinson D, Von Baeyer CL, Stinson JN, Sung L: A systematic review of faces scales for the self-report of pain intensity in children. Pediatrics. 2010, 126: 1168-1198. 10.1542/peds.2010-1609.CrossRef
30.
Nielsen S, Ruperto N, Herlin T, Pedersen FK: The Danish version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol. 2001, 19: 50-54.
31.
Thastum M, Zachariae R, Scholer M, Herlin T: A Danish adaptation of the Pain Coping Questionnaire for children: preliminary data concerning reliability and validity. Acta Paediatr. 1998, 88: 132-138.CrossRef
32.
Jensen MP, Turner JA, Romano JM, Lawler BK: Relationship of Pain-Specific Beliefs to Chronic Pain Adjustment. Pain. 1994, 57: 301-309. 10.1016/0304-3959(94)90005-1.CrossRefPubMed
33.
Field A: Discovering Statictic Using SPSS. 2009, London: SAGE
34.
Stinson JN, Stevens BJ, Feldman BM, Streiner D, McGrath PJ, Dupuis A, Gill N, Petroz GC: Construct validity of a multidimensional electronic pain diary for adolescents with arthritis. Pain. 2008, 136: 281-292. 10.1016/j.pain.2007.07.002.CrossRefPubMed
35.
Taylor P, Manger B, Alvaro-Gracia J, Johnstone R, Gomez-Reino J, Eberhardt E, Wolfe F, Schwartzman S, Furfaro N, Kavanaugh A: Patient perceptions concerning pain management in the treatment of rheumatoid arthritis. J Int Med Res. 2010, 38: 1213-1224.CrossRefPubMed
36.
Varni JW, Thompson KL, Hanson V: The Varni/Thompson Pediatric Pain Questionnaire. l. Chronic musculoskeletal pain in juvenile rheumatoid arthritis. Pain. 1987, 28: 27-38. 10.1016/0304-3959(87)91056-6.CrossRefPubMed
37.
Gragg RA, Rapoff MA, Danovsky MB, Lindsley CB, Varni JW, Waldron SA, Bernstein BH: Assessing chronic musculoskeletal pain associated with rheumatic disease: Further validation of the Pediatric Pain Questionnaire. J Pediatr Psychol. 1996, 21: 237-250. 10.1093/jpepsy/21.2.237.CrossRefPubMed
38.
Leegaard A, Lomholt JJ, Thastum M, Herlin T: Decreased Pain Threshold in Juvenile Idiopathic Arthritis: A Cross-Sectional Study. J Rheumatol. 2013, in press
39.
Hogeweg JA, Kuis W, Huygen AC, Bernards A, Oostendorp RA, Helders PJ, de Jong de vos van Steenwijk C: The pain threshold in juvenile chronic arthritis. Br J Rheumatol. 1995, 34: 61-67. 10.1093/rheumatology/34.1.61.CrossRefPubMed
40.
Thastum M, Zachariae R, Scholer M, Bjerring P, Herlin T: Cold pressor pain: comparing responses of juvenile arthritis patients and their parents. Scand J Rheumatol. 1997, 26: 272-279. 10.3109/03009749709105316.CrossRefPubMed
41.
Graven-Nielsen T, Arendt-Nielsen L: Peripheral and central sensitization in musculoskeletal pain disorders: an experimental approach. Curr Rheumatol Rep. 2002, 4: 313-321. 10.1007/s11926-002-0040-y.CrossRefPubMed
42.
Woolf CJ: Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011, 152: 2-15. 10.1016/j.pain.2010.05.007.CrossRef
43.
Anthony KK, Schanberg LE: Assessment and Management of Pain Syndromes and Arthritis Pain in Children and Adolescents. Rheum Dis Clin North Am. 2007, 33: 625-660. 10.1016/j.rdc.2007.07.010.CrossRefPubMed
44.
Gatchel RJ, Peng YB, Peters ML, Fuchs PN, Turk DC: The Biopsychosocial Approach to Chronic Pain: Scientific Advances and Future Directions. Psychol Bull. 2007, 133: 581-624.CrossRefPubMed
45.
Schanberg LE, Anthony KK, Gil KM, Lefebvre JC, Kredich DW, Macharoni LM: Family Pain History Predicts Child Health Status in Children With Chronic Rheumatic Disease. Pediatrics. 2001, 108: 47-10.1542/peds.108.3.e47.CrossRef
46.
Hagglund KJ, Vieth AZ, Sadler CS, Johnson JC, Hewett JE: Caregiver personality characteristics and adaptation to juvenile rheumatic disease. Rehabil Psychol. 2000, 45: 242-259.CrossRef
47.
Ross CK, Lavigne JV, Sinacore JM, Pachman LM: Psychosocial Factors Affecting Reported Pain in Juvenile Rheumatiod Arthritis. J Pediatr Psychol. 1993, 18: 561-573. 10.1093/jpepsy/18.5.561.CrossRefPubMed
48.
Iobst E, Nabors L, Brunner H, Precht B: Pain, Fatigue, Family Functioning, and Attitude Toward Illness in Children with Juvenile Rheumatic Diseases. J Dev Phys Disabil. 2007, 19: 135-144. 10.1007/s10882-006-9028-2.CrossRef
49.
Barlow JH, Shaw KL, Wright CC: Development and preliminary validation of a children’s arthritis self- efficacy scale. Arthritis Rheum. 2001, 45: 159-166. 10.1002/1529-0131(200104)45:2<159::AID-ANR169>3.0.CO;2-2.CrossRefPubMed
50.
Vuorimaa H, Honkanen V, Konttinen YT, Komulainen E, Santavirta N: Improved factor structure for self-efficacy scales for children with JIA (CASE) and their parents (PASE). Clin Exp Rheumatol. 2007, 25: 494-501.PubMed
51.
Vuorimaa H, Tamm K, Honkanen V, Konttinen YT, Komulainen E, Santavirta N: Empirical classification of children with JIA: a multidimensional approach to pain and well-being. Clin Exp Rheumatol. 2008, 26: 954-961.PubMed
52.
Sallfors C, Hallberg LR, Fasth A: Well-being in children with juvenile chronic arthritis. Clin Exp Rheumatol. 2004, 22: 125-130.PubMed
53.
Shaw KL, Southwood TR, McDonagh JE, Duffy CM: Health-related quality of life in adolescents with juvenile idiopathic arthritis. Arthritis Care Res. 2006, 55: 199-207. 10.1002/art.21852.CrossRef
54.
Perquin CW, Hazebroek-Kampschreur AA, Hunfeld JA, Bohnen AM, van Suijlekom-Smit LW, Passchier J, van der Wouden JC: Pain in children and adolescents: a common experience. Pain. 2000, 87: 51-58. 10.1016/S0304-3959(00)00269-4.CrossRefPubMed
55.
Merlijn VPBM, Hunfeld JAM, van der Wouden JC, Hazebroek-Kampschreur AAJM, Koes BW, Passchier J: Psychosocial factors associated with chronic pain in adolescents. Pain. 2003, 101: 33-43. 10.1016/S0304-3959(02)00289-0.CrossRefPubMed
56.
Thomsen AH, Compas BE, Colletti RB, Stanger C, Boyer MC, Konik BS: Parent reports of coping and stress responses in children with recurrent abdominal pain. J Pediatr Psychol. 2002, 27: 215-226. 10.1093/jpepsy/27.3.215.CrossRefPubMed
57.
Turner JA, Holtzman S, Mancl L: Mediators, moderators, and predictors of therapeutic change in cognitive-behavioral therapy for chronic pain. Pain. 2007, 127: 276-286. 10.1016/j.pain.2006.09.005.CrossRefPubMed
58.
Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G, Malattia C, Viola S, Martini A, Ravelli A: Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum. 2009, 61: 658-666. 10.1002/art.24516.CrossRefPubMed
Metadata
Title
Pain experience in children with juvenile idiopathic arthritis treated with anti-TNF agents compared to non-biologic standard treatment
Authors
Johanne Jeppesen Lomholt
Mikael Thastum
Troels Herlin
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Pediatric Rheumatology / Issue 1/2013
Electronic ISSN: 1546-0096
DOI
https://doi.org/10.1186/1546-0096-11-21

Other articles of this Issue 1/2013

Pediatric Rheumatology 1/2013 Go to the issue

Notice of redundant publication

Notice of redundant publication: Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA)

Research

Evaluation of anti-citrullinated type II collagen and anti-citrullinated vimentin antibodies in patients with juvenile idiopathic arthritis

Research

Mothers’ reports of the difficulties that their children experience in taking methotrexate for Juvenile Idiopathic Arthritis and how these impact on quality of life

Research

Maximal mouth opening capacity: percentiles for healthy children 4–17 years of age

Research

Clinical patterns of juvenile idiopathic arthritis in Zambia

Review

pGALS – paediatric Gait Arms Legs and Spine: a simple examination of the musculoskeletal system